Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Depreciation and Depletion (2016 - 2017)

Historic Depreciation and Depletion for Tenax Therapeutics (TENX) over the last 7 years, with Q4 2017 value amounting to $2621.0.

  • Tenax Therapeutics' Depreciation and Depletion fell 3367.91% to $2621.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $12621.0, marking a year-over-year decrease of 3340.54%. This contributed to the annual value of $7570.0 for FY2023, which is 4719.04% up from last year.
  • Per Tenax Therapeutics' latest filing, its Depreciation and Depletion stood at $2621.0 for Q4 2017, which was down 3367.91% from $3000.0 recorded in Q3 2017.
  • Tenax Therapeutics' Depreciation and Depletion's 5-year high stood at $23000.0 during Q1 2013, with a 5-year trough of $2621.0 in Q4 2017.
  • For the 5-year period, Tenax Therapeutics' Depreciation and Depletion averaged around $13561.5, with its median value being $16836.0 (2015).
  • Its Depreciation and Depletion has fluctuated over the past 5 years, first changed by 0.0% in 2013, then tumbled by 4090.91% in 2015.
  • Quarter analysis of 5 years shows Tenax Therapeutics' Depreciation and Depletion stood at $23000.0 in 2013, then fell by 8.7% to $21000.0 in 2014, then crashed by 38.1% to $13000.0 in 2015, then tumbled by 69.6% to $3952.0 in 2016, then crashed by 33.68% to $2621.0 in 2017.
  • Its last three reported values are $2621.0 in Q4 2017, $3000.0 for Q3 2017, and $3000.0 during Q2 2017.